Understanding DDX27: Potential Cancer Drug Target (G55661)

Target Name: DDX27

NCBI ID: G55661

DDX27

Understanding DDX27: Potential Cancer Drug Target

DDX27 (Drs1p) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the homeobox gene family, which is a family of genes that are involved in the development and maintenance of tissues and organs.

One of the functions of DDX27 is to regulate the development and progression of cancer. It has been shown to play a role in the development of various types of cancer, including breast, ovarian, and colorectal cancer.

In addition to its role in cancer development, DDX27 has also been shown to be involved in the regulation of cellular processes that are important for the survival and growth of tissues. It has been shown to play a role in the regulation of cell division, cell migration, and the formation of blood vessels.

Because of its involvement in these processes, DDX27 has been identified as a potential drug target. Researchers are studying the effects of drugs that can interact with DDX27 in order to determine if these drugs can be used to treat various types of cancer.

One of the challenges in studying DDX27 as a drug target is its complex structure. Because it is a protein, it is difficult to study using traditional methods such as RNA interference or protein synthesis.

In order to study DDX27 more effectively, researchers have developed a number of techniques that can help to understand its functions. These techniques include mass spectrometry, which is a technique that can be used to identify the amino acids that make up a protein, and yeast two-hybrid assays, which are used to study the interactions between proteins and small molecules.

Researchers have also used other techniques to study the functions of DDX27. These include in vitro studies, which involve testing the effects ofDDX27 on cells grown in a laboratory setting, and animal models of cancer, which can be used to study the effects of DDX27 on the growth and development of cancer in animals.

Despite these efforts, much more research is needed in order to fully understand the functions of DDX27 and its potential as a drug target. Further studies are needed to determine the exact mechanisms by which DDX27 functions, and to identify the most effective ways to use it as a treatment for cancer.

In conclusion, DDX27 is a protein that is involved in the development and progression of cancer, as well as the regulation of cellular processes that are important for tissue survival and growth. As a result, it has been identified as a potential drug target for the treatment of various types of cancer. Further research is needed to fully understand its functions and to develop effective treatments.

Protein Name: DEAD-box Helicase 27

Functions: Probable ATP-dependent RNA helicase. Component of the nucleolar ribosomal RNA (rRNA) processing machinery that regulates 3' end formation of ribosomal 47S rRNA (PubMed:25825154)

The "DDX27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets